TriMarkPublications.com cites in its newly published "Veterinary Health Markets" report that the global veterinary health products market is forecasted to spike to over $28 billion by 2017.
Veterinary health products can be categorized into three main groups: veterinary pharmaceuticals, biologicals and medicated feed additives (MFAs).
The veterinary health market for 2011 is estimated at $21.1 billion and 63% of this amount is accounted for by pharmaceuticals ($13.3 billion), 25% by biologicals ($5.27 billion) and 12% by medicinal feed additives ($2.5 billion).
Food animal healthcare comprised $12.45 billion of the total 2011 market; companion animal healthcare comprised $8.64 billion.
Detailed charts with sales forecasts and market share data are included. For more information, visit TriMarkPublications.com
The "Veterinary Health Markets" report examines companies manufacturing veterinary health equipment and supplies in the world. Companies covered include: Abaxis, Abbott, Adiagene, Adisseo France, Alpharma, Avian, BASF, Bayer, Biobest, Biocurex, BioVet, Boehringer Ingelheim, CEVA Sante Animale, CJ, Cyprus, Dabaco Viet Nam, DayMoon, Dow AgroSciences, DuPont Qualicon, ECO, EIPICO, Elanco, Eurofins Medigenomix GmbH, Eurovet Animal Health, Gene Check, Heska, Huvepharma, Idexx, IWAKI & Co., Jansen, Laboklin, Medika, Merck & Co., Merial, MetaMorphix, Microbix, Momina krepost AD Veliko Tarnovo, Mosaic, Neogen, Norbrook, Novartis, Novus International, OptiGen, Orion, PETCO, PetSmart, PAHC, Phylaxia 1912 Holding NyRt, Piedmont, Pfizer, Prionics AG, Randox, Sanofi-Aventis, Sequent Scientific, Skystar, Sunwin International Nutraceuticals, Synbiotics, Teva, The Arab Pesticides and Veterinary Drugs Mfg. Co., ThermoGenesis, VCA Antech, Velefarm ad Beograd, Veterinarski Zavod Subotica ad Subotica, Vetoquinol, Virbac and Woogene.